Detection of treated liver metastases using fluorine-18-fluordeoxyglucose (FDG) and positron emission tomography (PET)

Anticancer Research

Volumn 19, Issue 5 C, 1999, Pages 4443-4450

  Mantaka, Panagiota ^a   Dimitrakopoulou Strauss, Antonia ^a   Strauss, Ludwig G ^a   Moehler, Markus ^b   Goldschmidt, Hartmut ^d   Oberdorfer, Franz ^c   Kontaxakis, George ^a   Van Kaick, Gerhard ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d NONE

Author keywords

FDG; Liver; Metastases; PET; Treatment

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FOLLOW UP; HUMAN; LIVER METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REFERENCE VALUE;

BLOOD GLUCOSE; EVALUATION STUDIES; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033403848     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. John W, Hodgson B: Hepatic resections. In: Liver Tumors: Multidisciplinary managent (John W Hodgson B, eds) St. Louis, Missouri, USA, Warren H. Green, Inc., 1988, pp 185-228.
2. Dumas O, Roget L, Coppere H et al: Comparative study of the data of fine-needle aspiration biopsy and echographic aspects of hepatic tumors as a function of the circumstances of discovery. Apropos of 206 patients. Gastroenterol Clin Biol 14(1): 67-73, 1990.
3. Schiepers C, Penninckx F, De Vadder N et al: Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. Eur J Surg Oncol 21: 517-522, 1995.
4. Strauss LG, Conti P: The applications of PET in clinical oncology. J Nucl Med 32: 623-648, 1991.
5. Rigo P, Paulus P, Kaschten BJ et al: Oncological applications of positron emission tomography with fluorine-18-deoxyglucose. Eur J Nucl Med 1641-1674, 1996.
6. Strauss LG: Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 23: 1409-1415, 1996.
7. Strauss LG. Positron emission tomography for therapy management. In: Tumor response monitoring and treatment planning, 1st edition. (Breit A, Heuck A, Lukas P, Kneschaurek P, Mayr M, eds.). Berlin: Springer-Verlag 1992, pp25-28.
8. Dimitrakopoulou-Strauss A, Strauss LG, Tilgen W, Oberdorfer F, van Kaick G: PET studies with F-18-deoxyglucose and O-15 labelled water in patients with liver metastases. In: Tomography in Nuclear Medicine, ed. International atomic energy agency. Vienna 1996, 185-193.
9. Fröhlich A, Diederichs CG, Staib L, Vogel J, Beger HG and Reske SN: Detection of liver metastases from pancreatic cancer using FDG PET. J Nucl Med 40: 250-255, 1999.
10. Imbriaco M, Yeung HWD, Macapinlac H et al: Whole body PET-FDG in patients with recurrent colorectal carcinoma: comparison with CT. J Nucl Med 136-137, 1997.
11. Gupta N, Bradfield H: Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms. Semin Nucl Med 26(1): 65-73, 1996.
12. Toorongian SA, Mulholland GK, Jewett DM et al: Routine production of 2-deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin. Nucl Med Biol 1990, 3: 273-279,
13. Kontaxakis G, Tzanakos GS, Strauss LG, Dimitrakopoulou-Strauss A, Mantaka P, van Kaick G: Characteristics of the local convergence behavior of the iterative ML-EM image reconstruction algorithms. J Nucl Med 38: P202, 1997.
14. Hoverath H, Kuebler WK, Ostertag et al: Scatter correction in the transaxial slices of a whole-body positron emission tomograph. Phys Med Biol 38: 712-728, 1993.
15. Lai DTM, Fulham M, Stephen MS et al: The role of whole-body positron emission tomography with [F-18]-fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 131: 703-707, 1996.
16. Vitola JV, Delbeke D, Sandler MP et al: Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 171: 21-26, 1996.
17. Smith FW, Heys SD, Evans NTS et al: Pattern of 2-deoxy-2-(F-18)-fluoro-D-glucose accumulation in liver tumours: primary, metastatic and after chemotherapy. Nucl Med Comm 13: 193-195, 1992.
18. Delbeke D, Limor J, Chapman WC, Wright JK and Pinson CW: Value of FDG-PET in the assessment of liver neoplasms. J Nucl Med 137, 1997.
19. Findlay M, Young H, Cunningham D et al: Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor responce to fluorouracil. J Clin Oncol 14(3): 700-708, 1996.
20. Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H et al: Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas. Eur J Nucl Med 22: 434-442, 1995.
21. Eil A, Dimitrakopoulou-Strauss A, Tilgen W, Oberdorfer F, Doll J and Strauss LG: Functional imaging with positron emission tomography in patients with malignant melanoma. Onkologie 19: 253-259, 1996.
22. Ostertag H, Kübler WK, Doll J and Lorenz WJ: Measured attenuation correction methods. Eur J Nucl Med 15: 722-726, 1989.
23. Hoffman EJ, Huang SC and Phelps ME: Quantitation in positron emission computed tomography: 1. Effect of object size. J Comput Assist Tomogr 93: 299-308, 1979.
24. Torizuka T, Tamaki N, Inokuma T et al: Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. J Nucl Med 35: 1965-1969, 1994.
25. Messa C, Choi Y, Hoh CK et al: Quantification of glucose utilization in liver metastases: Parametric imaging of FDG uptake with PET. J Comput Assist Tomogr 16(5): 684-689, 1992.
26. Conti PS: Synthesis of carbon-11 labeled biological molecules for the in vivo study of biochemical processes and structure-activity relationships in normal and malignant tissues. Diss Abstr Int Sci 47(7): 2731, 1987.
27. Dimitrakopoulou-Strauss A, Strauss LG, Tilgen W et al: PET with F-18-Dihydroxyphenylalanine (F-18-DOPA) in patients with malignant melanomas. Eur J Nucl Med 24(8): 1026, 1997.
28. Schwarzbach M, Willeke F, Dimitrakopoulou-Strauss A, et al: Functional imaging and detection of local recurrence in soft tissue sarcomas by positron emission tomography. Anticancer Res 19: 1343-1350, 1999.